Preferential Tumor Vascular Damage Is the Common Antitumor Mechanism of High-Dose Hypofractionated Radiation Therapy: SABR, Spatially Fractionated Radiation Therapy, and FLASH Radiation Therapy

Chang W. Song; Stephanie Terezakis; Woo Yoon Park; Sun Ha Paek; Mi Sook Kim; L. Chinsoo Cho; Robert J. Griffin

doi:10.1016/j.ijrobp.2023.05.015

Preferential Tumor Vascular Damage Is the Common Antitumor Mechanism of High-Dose Hypofractionated Radiation Therapy: SABR, Spatially Fractionated Radiation Therapy, and FLASH Radiation Therapy

Chang W. Song, Stephanie Terezakis, Woo Yoon Park, Sun Ha Paek, Mi Sook Kim, L. Chinsoo Cho, Robert J. Griffin

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	701-704
Number of pages	4
Journal	International Journal of Radiation Oncology Biology Physics
Volume	117
Issue number	3
DOIs	https://doi.org/10.1016/j.ijrobp.2023.05.015
State	Published - Nov 1 2023

PubMed: MeSH publication types

Editorial

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Publisher link

10.1016/j.ijrobp.2023.05.015

Find It

Find It at U of M Libraries

Cite this

Song, C. W., Terezakis, S., Park, W. Y., Paek, S. H., Kim, M. S., Cho, L. C., & Griffin, R. J. (2023). Preferential Tumor Vascular Damage Is the Common Antitumor Mechanism of High-Dose Hypofractionated Radiation Therapy: SABR, Spatially Fractionated Radiation Therapy, and FLASH Radiation Therapy. International Journal of Radiation Oncology Biology Physics, 117(3), 701-704. https://doi.org/10.1016/j.ijrobp.2023.05.015

Preferential Tumor Vascular Damage Is the Common Antitumor Mechanism of High-Dose Hypofractionated Radiation Therapy: SABR, Spatially Fractionated Radiation Therapy, and FLASH Radiation Therapy. / Song, Chang W.; Terezakis, Stephanie; Park, Woo Yoon et al.
In: International Journal of Radiation Oncology Biology Physics, Vol. 117, No. 3, 01.11.2023, p. 701-704.

Research output: Contribution to journal › Article › peer-review

Song, CW, Terezakis, S, Park, WY, Paek, SH, Kim, MS, Cho, LC & Griffin, RJ 2023, 'Preferential Tumor Vascular Damage Is the Common Antitumor Mechanism of High-Dose Hypofractionated Radiation Therapy: SABR, Spatially Fractionated Radiation Therapy, and FLASH Radiation Therapy', International Journal of Radiation Oncology Biology Physics, vol. 117, no. 3, pp. 701-704. https://doi.org/10.1016/j.ijrobp.2023.05.015

Song CW, Terezakis S, Park WY, Paek SH, Kim MS, Cho LC et al. Preferential Tumor Vascular Damage Is the Common Antitumor Mechanism of High-Dose Hypofractionated Radiation Therapy: SABR, Spatially Fractionated Radiation Therapy, and FLASH Radiation Therapy. International Journal of Radiation Oncology Biology Physics. 2023 Nov 1;117(3):701-704. doi: 10.1016/j.ijrobp.2023.05.015

@article{7f6a209b070c45fb8a632fd92b93a6bb,

title = "Preferential Tumor Vascular Damage Is the Common Antitumor Mechanism of High-Dose Hypofractionated Radiation Therapy: SABR, Spatially Fractionated Radiation Therapy, and FLASH Radiation Therapy",

author = "Song, {Chang W.} and Stephanie Terezakis and Park, {Woo Yoon} and Paek, {Sun Ha} and Kim, {Mi Sook} and Cho, {L. Chinsoo} and Griffin, {Robert J.}",

year = "2023",

month = nov,

day = "1",

doi = "10.1016/j.ijrobp.2023.05.015",

language = "English (US)",

volume = "117",

pages = "701--704",

journal = "International Journal of Radiation Oncology Biology Physics",

issn = "0360-3016",

publisher = "Elsevier Inc.",

number = "3",

}

TY - JOUR

T1 - Preferential Tumor Vascular Damage Is the Common Antitumor Mechanism of High-Dose Hypofractionated Radiation Therapy

T2 - SABR, Spatially Fractionated Radiation Therapy, and FLASH Radiation Therapy

AU - Song, Chang W.

AU - Terezakis, Stephanie

AU - Park, Woo Yoon

AU - Paek, Sun Ha

AU - Kim, Mi Sook

AU - Cho, L. Chinsoo

AU - Griffin, Robert J.

PY - 2023/11/1

Y1 - 2023/11/1

UR - http://www.scopus.com/inward/record.url?scp=85161010034&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85161010034&partnerID=8YFLogxK

U2 - 10.1016/j.ijrobp.2023.05.015

DO - 10.1016/j.ijrobp.2023.05.015

M3 - Article

C2 - 37196835

AN - SCOPUS:85161010034

SN - 0360-3016

VL - 117

SP - 701

EP - 704

JO - International Journal of Radiation Oncology Biology Physics

JF - International Journal of Radiation Oncology Biology Physics

IS - 3

ER -

Preferential Tumor Vascular Damage Is the Common Antitumor Mechanism of High-Dose Hypofractionated Radiation Therapy: SABR, Spatially Fractionated Radiation Therapy, and FLASH Radiation Therapy

PubMed: MeSH publication types

UN SDGs

Publisher link

Find It

Other files and links

Cite this